WELLS FARGO & COMPANY/MN - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 205 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$59,058
-93.7%
17,370
-86.4%
0.00%
Q2 2023$938,113
+0.2%
127,635
+41.2%
0.00%
Q1 2023$936,279
+318.6%
90,374
+377.2%
0.00%
Q4 2022$223,670
-0.1%
18,939
+77.2%
0.00%
Q3 2022$224,000
-95.9%
10,687
-93.9%
0.00%
-100.0%
Q2 2022$5,451,000
-54.1%
175,610
-39.3%
0.00%
-33.3%
Q1 2022$11,874,000
-13.5%
289,150
-8.4%
0.00%0.0%
Q4 2021$13,730,000
-34.3%
315,832
-24.3%
0.00%
-40.0%
Q3 2021$20,887,000
+13.9%
417,151
+43.3%
0.01%
+25.0%
Q2 2021$18,334,000
-57.2%
291,058
-36.9%
0.00%
-60.0%
Q1 2021$42,882,000
+8.0%
461,552
+4.1%
0.01%0.0%
Q4 2020$39,719,000
-36.7%
443,297
-27.1%
0.01%
-41.2%
Q3 2020$62,793,000
+70.0%
607,711
+30.1%
0.02%
+54.5%
Q2 2020$36,942,000
+36.1%
467,153
-0.4%
0.01%
+22.2%
Q1 2020$27,150,000
+61.9%
469,227
+51.0%
0.01%
+80.0%
Q4 2019$16,767,000
-3.1%
310,805
-6.1%
0.01%0.0%
Q3 2019$17,311,000
+4.1%
331,121
-3.8%
0.01%0.0%
Q2 2019$16,628,000
+109.8%
344,191
+119.5%
0.01%
+150.0%
Q1 2019$7,924,000
-8.8%
156,832
+7.1%
0.00%
-33.3%
Q4 2018$8,685,000
-10.2%
146,490
-0.3%
0.00%0.0%
Q3 2018$9,676,000
+39.3%
146,984
+6.8%
0.00%
+50.0%
Q2 2018$6,947,000
-10.5%
137,589
-6.6%
0.00%0.0%
Q1 2018$7,759,000
+26.2%
147,357
+11.4%
0.00%0.0%
Q4 2017$6,149,000
+66.7%
132,305
+45.2%
0.00%
+100.0%
Q3 2017$3,688,000
+47.3%
91,136
+23.5%
0.00%0.0%
Q2 2017$2,504,000
+17.2%
73,812
+0.3%
0.00%0.0%
Q1 2017$2,136,000
-37.7%
73,570
-29.5%
0.00%0.0%
Q4 2016$3,426,000
-56.8%
104,347
-58.5%
0.00%
-66.7%
Q3 2016$7,922,000
+224.1%
251,254
+189.1%
0.00%
+200.0%
Q2 2016$2,444,000
-14.5%
86,895
+10.6%
0.00%0.0%
Q1 2016$2,857,000
-0.8%
78,583
+9.2%
0.00%0.0%
Q4 2015$2,880,000
+80.3%
71,973
+28.3%
0.00%0.0%
Q3 2015$1,597,000
+115.2%
56,091
+149.1%
0.00%
Q2 2015$742,000
+4.2%
22,514
-9.2%
0.00%
Q1 2015$712,000
+63.7%
24,786
+55.1%
0.00%
Q4 2014$435,000
+27.9%
15,982
+0.3%
0.00%
Q3 2014$340,000
-13.3%
15,931
-8.8%
0.00%
Q2 2014$392,000
+1.0%
17,460
+13.7%
0.00%
Q1 2014$388,000
+9.9%
15,362
+0.0%
0.00%
Q4 2013$353,000
+20.1%
15,358
-0.6%
0.00%
Q3 2013$294,000
+87.3%
15,454
+41.9%
0.00%
Q2 2013$157,00010,8890.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders